Daily Stock List
Halo Companies, Inc. (HALN)
Stock Guru reported previously on Halo Companies, Inc. (HALN), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Founded in 2004, Halo Companies, Inc. is a nationwide distressed asset services company. They provide technology-driven asset management, portfolio analytics, acquisition, repositioning and liquidation strategies for the private investment and mortgage servicing industry. Halo Companies lists on the OTCQB. The Company is based in Allen, Texas.
Halo Companies established their roots in the mortgage origination sector. They quickly grew to an award-wining consumer financial services company. The Company has emerged as a premier distressed asset services organization.
Halo Asset Management, LLC is a subsidiary of Halo Companies. Halo Asset Management developed a complete asset management platform that focuses on the monetization and servicing of distressed real estate assets to find a win-win solution for the asset owner and consumer. By way of a proprietary technology platform, sophisticated analytics and highly-skilled personnel, Halo Asset Management oversees all aspects of buying and managing distressed Real Estate Owned (REO) and non-performing loans.
In May, Halo Companies announced profitable first quarter results with revenue of $1.9 million and a net income of $279,000 for the quarter ended March 31, 2012. Revenue increased 124 percent over the same quarter in the prior year. Net income increased 125 percent over the same quarter in the prior year.
In June, Halo Asset Management announced the addition of Mr. Charles R. Carpenter as Vice President of Sales and Mr. Jody Garcia as Vice President of Fulfillment. Mr. Carpenter will oversee all sales activities. He brings more than 12 years of sales and leadership experience to the Company. Most recently, he served as the regional director for True Homes in Charlotte, North Carolina.
Mr. Garcia will direct the fulfillment portion of the asset management business. He will be responsible for creating efficiencies and improving processes to enhance production and curative timelines. Mr. Garcia is an accomplished professional in the financial services industry, bringing more than 10 years of experience to his new role. For the past four years he served as the portfolio specialist supervisor for GMAC Rescap.
Halo Companies, Inc. (HALN), closed Thursday’s trading session at $0.25, up 354.55%, on 200 volume with 2 trades. The average volume for the last 60 days is 281. The 52-week low/high is $0.05/$1.01.
Intellect Neurosciences, Inc. (ILNS)
OtcWizard reported recently on Intellect Neurosciences, Inc. (ILNS), Penny PayDay did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Intellect Neurosciences, Inc. is a biopharmaceutical company whose shares trade on the OTCQB. The Company engages in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases. Intellect Neurosciences has a specific focus on proteinopathies. Their pipeline includes therapeutic vaccines, antibodies and neuroprotective antibody drug conjugates. The Company is based in New York, New York.
The Company’s pipeline includes small neuroprotective molecules and neoepitope-based immunotherapy approaches, including monoclonal antibodies, antibody drug conjugates and vaccines targeting beta amyloid and abnormal tau proteins. Dr. Daniel Chain, Intellect Neurosciences’ Chairman and CEO, was the first in the biopharmaceutical industry to focus on preventing the accumulation and neurotoxicity of soluble amyloid beta as an approach to treating and preventing Alzheimer’s disease.
Intellect Neurosciences’ drug product pipeline includes OX1, which has been tested in Phase 1 clinical trials; IN-N01, a humanized monoclonal antibody designed to promote the clearance of soluble amyloid beta; and RECALL-VAX, a vaccine technology that has the potential to delay or prevent Alzheimer's disease in people who are at risk.
The Company developed OX1, a multimodal antioxidant molecule, through preclinical and human safety trials before licensing the program to ViroPharma. ViroPharma has said their plan is to enter Phase 2 clinical trials in patients with Friedreich's Ataxia, an orphan indication, in 2013. Intellect Neurosciences’ preclinical R&D pipeline is based on two proprietary platform technologies, CONJUMAB-A and RECALL-VAX.
Earlier this month, Intellect Neurosciences announced that they obtained a Notice of Allowance from the European Patent Office (EPO) for OX1, which has been licensed to ViroPharma for Friedrich's Ataxia and other neurodegenerative diseases. Separately, they received a similar notice from the Israeli patent office for the RECALL-VAX platform technology that underlies RV03, the Company’s first-in-class bi-specific vaccine targeting beta amyloid and delta tau for the treatment and prevention of Alzheimer's disease. The OX1 patent relates to a new salt form found to be useful to increase the purity of the compound during manufacture.
Intellect Neurosciences, Inc. (ILNS), closed Thursday’s trading at $0.01, even with yesterday’s close, on 112,892 volume with 10 trades. The average volume for the last 60 days is 624,220. The 52-week low/high is $0.006/$0.18.
Explore Anywhere Holding Corp. (EAHC)
Atomic Pennies reported this month on Explore Anywhere Holding Corp. (EAHC), Insider Wire did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Explore Anywhere Holding Corp. is in the business of selling computer monitoring software and hardware products. The Company specializes in offering computer monitoring solutions for parents, corporations and educational facilities. Originally founded and incorporated in 2002 as "ExploreAnywhere Software, LLC", the Company has been in the forefront of developing highly advanced computer monitoring and covert surveillance software technologies. Explore Anywhere Holding has their headquarters in Wabash, Indiana.
Explore Anywhere Holding’s mission is to provide effective and useful computer monitoring products at affordable prices. This is their corporate effort to cut down on the dangers of the Internet and the greater community at large. The Company’s solutions implement technologies designed to address an assortment of emerging online threats. Explore Anywhere Holding works to offer functional, user-friendly software products with innovative features and functionality.
The Company offers SpyBuddy 2012. This is the award-winning, powerful Internet spy software and computer monitoring product that allows one to monitor spouses, children, employees, or almost anyone else. SpyBuddy spy software allows one to secretly monitor all areas of their PC. They can track every action down to the last keystroke pressed and the last file deleted. SpyBuddy 2012 monitoring software is virtually undetectable and very user-friendly.
Explore Anywhere Holding also offers their Keylogger Pro 2012 Remote Keylogger Software. Keylogger Pro silently records keystrokes typed on any keyboard layout (English, Russian, Chinese, Arabic, and more), as well as all passwords, emails, chats and social network activity typed by users of an individual’s computer.
This week, Explore Anywhere Holding commented on a significant product update enabling auto updates for future new features and software maintenance. The update is currently active in Keylogger PRO 2012 and will soon be active in SpyBuddy 2012. The update enables product installation without a computer re-boot, remote un-installation through the Explore Anywhere Customer Account, resistance to tampering and circumvention, and installation without the need to disable anti-virus programs.
Explore Anywhere Holding Corp. (EAHC), closed Thursday’s trading session at $0.30, up 0.33%, on 65,102 volume with 32 trades. The average volume for the last 60 days is 336,626. The 52-week low/high is $0.09/$0.35.
Mobile Integrated Systems, Inc. (MIBI)
Research Driven Alerts, Growing Stocks Reports, Michael Stone, PickPennyStocks, Canadian Microcap Report, Stockdigest Report, Research Driven Investor, SmallCapInvestorDaily, OTCtipReporter, and Penny Stock SMS Publisher reported recently on Mobile Integrated Systems, Inc. (MIBI). PennyStockScholar, SmallCapInvestor, and PennyTrader did as well, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Mobile Integrated Systems, Inc. (MOBI) is a technology company with corporate headquarters in Toronto, Ontario. The Company’s focus is on developing and deploying mobile products and transaction systems to an array of industry sectors. These include lotteries, gaming, transportation, telecommunications, finance, and others. Founded in 2008, the Company was formerly known as Loto, Inc. They changed their name to Mobile Integrated Systems, Inc. in March of this year.
The Company’s technology solutions provide clients and partners with such features and benefits as secure electronic transactions, analytics, realistic game play, geolocation, and more. MOBI is developing a patent-pending software application which permits the secure purchase of lottery tickets on commercially available "smart" phones and similar mobile telecommunications devices. The Company’s proprietary technology addresses all elements of lottery play, including secure player registration and authorization, number selection, settlement, winning number notification and other direct-to-customer marketing opportunities.
MOBI’s intention is to license their software application to governments and other lottery operators as the Company’s primary source of revenue. However, they do not intend to become a lottery operator. MOBI expects to pursue their business outside of the U.S. The Company’s plan of business is to launch their mobile lottery application in the target markets of the Caribbean, Canada, Mexico, South America, Asia (China, Vietnam), Africa, Europe (Turkey and the United Kingdom of Great Britain) and the Eastern bloc region.
Late last month, MOBI and Quantitative Alpha Trading, Inc. (QAT) announced the execution of a binding term sheet providing that MOBI will acquire all of the outstanding common shares of QAT in exchange for 60,189,332 shares of MOBI's Common Stock. The Parties intend to complete the Transaction by way of amalgamation pursuant to a plan of arrangement under the Business Corporations Act (Ontario). Despite the foregoing, the Parties will continue to review alternative methods of completing the Transaction with a view to effecting the combination in the most effective manner having regard to legal, tax and regulatory considerations.
Mobile Integrated Systems, Inc. (MIBI), closed Thursday’s trading session at $0.26, down 22.94%, on 22,000 volume with 18 trades. The average volume for the last 60 days is 86,118. The 52-week low/high is $0.10/$0.41.
Quantum Rare Earth Developments Corp. (QREDF)
Today we are reporting on Quantum Rare Earth Developments Corp. (QREDF), here at the QualityStocks Daily Newsletter.
Quantum Rare Earth Developments Corp. is an exploration stage company that lists on the OTCQX International. The Company engages in the acquisition and exploration of mineral resource properties. Quantum is developing their 100 percent owned Elk Creek Carbonatite project in Nebraska. This is the only primary niobium deposit known to be under development in the United States, and the highest grade undeveloped niobium deposit in North America.
The Company was formerly known as Butler Resource Corp. They changed their name to Quantum Rare Earth Developments Corp. in March of 2010. Quantum Rare Earth has their corporate headquarters in Vancouver, British Columbia.
Niobium is primarily used in the form of Ferro-Niobium to produce HSLA (High Strength, Low Alloy) steel, to produce lighter, stronger steel for use in automotive, structural and pipeline industries. The United States imports 100 percent of their niobium needs. Niobium is listed as a strategic metal; it is being considered for national stockpiling in the U.S., China, and a number of European countries.
Quantum acquired the Elk Creek project in South East Nebraska on May 4, 2010. The Elk Creek project is a former Molycorp project. The Elk Creek Carbonatite is located in southeastern Nebraska an hour south of Lincoln. The niobium deposit is approximately 800 x 400 x 400 meters. The deposit is open in 3 directions including at depth.
In July, Quantum Rare Earth Developments announced that they finalized the previously announced option of the Company's Australian Jungle Well and Laverton properties (the Australian Properties). Under the terms of an option agreement dated September 19, 2011 (Florella Option Agreement), the Company granted Florella Holdings Pty Ltd. the right to earn an 80 percent interest in the Australian Properties, upon completion of payment of cash and the issuance of shares to Quantum.
Florella assigned a portion of their interest to an unrelated third party, Victory Mines Ltd., an Australian company. Victory is headquartered in Perth, Australia. Quantum and their Australian subsidiary Northeast Minerals Pty Ltd. entered into a comprehensive Joint Venture Agreement and a Tenement Sale Agreement with Victory, their subsidiary Victory Exploration Pty. Ltd., and Florella regarding the Joint Venture of the Australian Properties.
Quantum Rare Earth Developments Corp. (QREDF), closed Thursday at $0.13, down 1.55%, on 5,000 volume. The average volume for the last 60 days is 29,583. The 52-week low/high is $0.10/$0.33.
Lightwave Logic, Inc. (LWLG)
SmallCap Fortunes, StockGuru, FeedBlitz, OTC Picks, StandoutStocks, and HotOTC reported earlier on Lightwave Logic, Inc. (LWLG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Lightwave Logic, Inc. is a development stage research and development company. The Company is producing prototype electro-optic demonstration devices and is moving toward commercialization of their high-activity, high-stability organic polymers for applications in electro-optical device markets. Lightwave Logic’s shares trade on the OTCQB. The Company has their corporate headquarters in Newark, Delaware.
Lightwave Logic is a technology company concentrating on the development of a Next Generation Non Linear Optical Polymer Materials Platform for applications in high speed fiber-optic data communications and optical computing. Electro-optical devices convert data from electric signals into optical signals for use in high-speed fiber-optic telecommunications systems and optical computers.
The Company has developed and is continuing to develop Application Specific Electro-Optic Polymers (ASEOP) and Non-Linear All-Optical Polymers (NLAOP) that have high electro-optic and optical activity. Both types of materials are thermally and photo-chemically stable. Lightwave Logic believes they could have utility across a wide spectrum of applications in devices.
Lightwave Logic engineers their proprietary electro-optic polymers at the molecular level for premier performance, stability, cost-efficiency and ease of processing. The Company expects their NLAOP polymers to broadly replace more expensive, lower-performance materials that are currently used in telecommunications, data communications, computing, photovoltaic cells, wireless, and satellite communication networks.
The high-performance electro-optic materials that Lightwave Logic produces have demonstrated stability as high as 350 degrees Celsius. Stability above 250 degrees Celsius is necessary for vertical integration into many semi-conductor production lines. In December 2011, one of the Company’s non-linear optical polymers demonstrated an unusually high electro-optical effect of greater than 250 picometers per volt with excellent thermal and photo stability.
Independent research laboratories at Photon-X and The University of Colorado confirmed these characteristics. Lightwave Logic continues their development program on their new material, Perkinamine Indigo™ to understand better the properties that gave the Company the results reported in December 2011.
Last month, Lightwave Logic announced that Mr. Charles L. Greenlee joined the Company's Research and Development team, effective August 15, 2012. Since August 2005 Mr. Greenlee has been a graduate research assistant under Dr. Robert A. Norwood at the University of Arizona in the Pegyghambarian/Fallahi research group where he was actively involved in various advanced optical research projects and the testing of Lightwave materials at the University.
Lightwave Logic, Inc. (LWLG), closed Thursday’s trading session at $0.93, even with yesterday’s close, on 15,950 volume with 8 trades. The average volume for the last 60 days is 11,649. The 52-week low/high is $0.58/$3.33.
Alix Resources Corp. (AIX.V)
Stockhouse reported previously on Alix Resources Corp. (AIX.V), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Vancouver, British Columbia, Alix Resources Corp. is a junior exploration company. The Company engages in the acquisition, exploration, and development of mineral resource properties in Canada and the U.S. Alix is actively seeking mineral opportunities and has a portfolio of projects, including a land package with 21 square miles of claims in close proximity to Sumitomo's Pogo Mine. Alix Resources shares trade on the TSX Venture Exchange.
Alix’s projects include Golden Zone and Money-Rock/West Pogo in Alaska, Cougar in British Columbia, as well as Arcadia in Nunavut, Canada. The Golden Zone gold-silver-copper deposit is located on the south flank of the Alaska Range in the Valdez Creek Mining District, approximately 12 miles west of the Parks Highway on State of Alaska owned lands. Alix Resources optioned the 24,500-acre Golden Zone property in the fall of 2010.
The Cougar claims total approximately 450 hectares in British Columbia, which host a historic BC Minfile Rare Earth Oxide (REO) occurrence. The Money Rock/West Pogo project is located 80 miles southeast of Fairbanks, and two miles west of the Pogo Gold Mine, which is operated by Sumitomo Metals Corp. and produces an average of close to 400,000 ounces of gold each year (Alaska Div. of Geol. and Geoph. Surveys Sp. Rept. 65, 2011). Alix controls 21 square miles (5,439 hectares) of State of Alaska Mining Claims in this important area.
The Arcadia Property is located at Arcadia Bay on the Coronation Gulf, 160 kilometers east of the community of Kugluktuk, Nunavut, and 150 kilometers west of the Hope Bay Gold Project, which is presently under development by Newmont Mining Corp. The property covers 1,280 hectares.
Recently, Alix Resources announced that they completed Phase One drilling at their Money Rock/West Pogo gold project. Phase One drilling focused on the West Pogo portion of the project, with two NQ core holes completed for a cumulative total meterage of 610 meters (2,002 ft.). Both holes encountered metagranite with broad intervals of brecciation, including zones of iron-stained sericite alteration and arsenopyrite.
Drillhole WP-12-01 was collared in a broad northeast-trending area of anomalous gold, defined by surface rock and soil assays on the northern edge of the West Pogo claims. Drillhole WP-12-02 was collared 832 meters (2,730 ft.) east-northeast of the first hole, and oriented northwest to test the eastern end of the NE-trending anomaly, where gold-in-soil values range from 20 ppb up to 163 ppb Au and a float grab sample of silicified metagranite returned 2.12 g/t Au.
Alix Resources Corp. (AIX.V), closed Thursday’s session at $0.07, down 6.67%, on 119,500 volume. The 52-week low/high is $0.06/$0.24.
Implant Sciences Corp. (IMSC)
Corporate Profile Media reported recently on Implant Sciences Corp. (IMSC), PennyStockVille, Stock Rich, Stockpalooza, MadPennyStocks, BullRally, CoolPennyStocks, HotOTC did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 1984, Implant Sciences Corp. is a high technology supplier of systems and sensors. The Company manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. Implant Sciences has developed proprietary technologies used in their commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and around the world. Implant Sciences has their corporate headquarters in Wilmington, Massachusetts, and the Company lists on the OTCQB.
Implant Sciences develops and manufactures explosive trace detection sensors and systems capable of detecting minute amounts of a broad array of military, commercial, and homemade explosives. Their patented technologies provide unique screening capabilities to extend and improve counter-terrorist and homeland security efforts.
The Company’s QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation. Implant Sciences’ QS-B220 benchtop explosives and narcotics trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act).
Implant Sciences’ products undergo deployment globally to enhance the safety and security of their customers in areas such as aviation security, force protection, subway security, customs and immigration, cargo security, critical infrastructure protection, ports and tunnels security, and VIP protection.
Last week, Implant Sciences announced the sale of Quantum Sniffer™ QS-H150 handheld explosives trace detectors into the Middle East for VIP protection. This week, Implant Sciences announced that the Company continues to gain customers in Nigeria, one of the largest economies in Africa. The latest shipment is to ASL Airlines Services in Lagos, Nigeria. The sale was made via Lagos-based A.C. Belgrave, an in-country distributor for Implant Sciences' products.
ASL Airlines Services is the leading provider of catering and hospitality services to international airlines and airports in Nigeria. ASL will use Implant Sciences' QS-H150 explosives trace detectors to execute security search initiatives. This includes, but is not limited to, screening food and beverage service carts catering to airplanes.
Implant Sciences Corp. (IMSC), closed Thursday’s trading session at $1.38, down 1.43%, on 230,380 volume with 111 trades. The average volume for the last 60 days is 276,531. The 52-week low/high is $0.32/$1.84.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.28, up 1.79%, on 29,655 volume with 14 trades. The stock’s average daily volume over the past 60 days is 24,663, and its 52-week low/high is $0.21/$1.00.
International Stem Cell Corp. announced the addition of Professor Evan Snyder and Dr. Rosasio Sánchez-Pernaute today as scientific advisors to the company’s ongoing Parkinson's disease program, bringing the invaluable expertise of two of the world's leading experts in Parkinson's disease and stem cell research to what is regarded by many as the tip of the spear in the fight against this devastating degenerative neurological disorder.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp Announces World-Renowned Scientists Join as Advisors on Parkinson's Disease Program
International Stem Cell Corporation to Host Second Quarter 2012 Financial Results Conference Call August 10
International Stem Cell Corporation's Co-Chairman and CEO Andrey Semechkin PhD Publishes Letter to Shareholders
Duma Energy Corp. (DUMA)
The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $1.50, up 3.45%, on 1,850 volume with 6 trades. The stock’s average daily volume over the past 60 days is 7,803, and its 52-week low/high is $1.10/$4.00.
Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.
The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.
Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.
The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer
Duma Energy Corp. Company Blog
Duma Energy Corp. News:
Duma Energy Acquires Interest in 5.3 Million-Acre African Concession
Duma Energy Enters Final Stage of Negotiations for African Concession
Duma Energy Provides Third Quarter Results and Demonstrates Positive Earnings
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.002, even with yesterday's close, on 52,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 14,880, and its 52-week low/high is $0.001/$0.018.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
CORRECTION -- Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Consorteum Completes Acquisition of Tarsin Inc.
USA Recycling Industries, Inc. (USRI)
The QualityStocks Daily Newsletter would like to spotlight USA Recycling Industries, Inc. (USRI). Today, USA Recycling Industries, Inc. closed trading at $0.06, even with yesterday's close, on 5,000 volume with 1 trades. The stock’s average daily volume over the past 60 days is 14,027, and its 52-week low/high is $0.03/$0.14.
USA Recycling Industries, Inc. (USRI) is a mid-market recyclable waste collection & disposal service, providing specialty recycling programs to commercial & industrial customers throughout North America. Operating through multiple company-owned & partnership recycling centers, the company primarily targets growth opportunities in the $75 billion global scrap metals market.
USA Recycling has operated since its inception in 2000, and its largest operating subsidiary, Scrap USA, since 2007 has been focused on and successful in servicing the automotive service center industry. It currently provides specialty recycling programs to more than 5,000 automotive service center locations operated by some of the most recognizable names in that retail category.
With a well-established national footprint, the company is now integrating other ancillary services such as the collection & disposal of other recyclable waste streams. USA Recycling has also opened the door to franchising opportunities and recently signed a proprietary revenue sharing agreement with Recycling Franchisors, Inc. Other initiatives to drive growth and boost prominence include the launch of a new website and relocation of executive offices.
USA Recycling has successfully contracted automotive waste-generators for collection & disposal services, selling the processed recyclable materials to end-user-consumers through the company's trading operations with offices in North America, India, and the United Arab Emirates. The company's primary aim is to maximize shareholder value while providing the highest level of quality waste collection & disposal services to its customers, ensuring its collected debris remain free of any U.S. landfills. Disclaimer
USA Recycling Industries, Inc. Company Blog
USA Recycling Industries, Inc. News:
USA Recycling Industries to Provide Scrap Metal Collection Services to ThyssenKrupp Elevator Americas
USA Recycling Industries Enters Oil Filter Collection and Disposal Services Agreement With Redwood Recycling
USA Recycling Industries Signs Letter of Intent to Expand Used Oil Filter Recycling Operations
Today before the opening bell, International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, announced that Professor Evan Snyder and Dr. Rosasio Sánchez-Pernaute are now scientific advisors on the company’s Parkinson’s disease program.
Evan Snyder, MD, PhD is a Professor at the Sanford-Burnham Medical Research Institute and director of Sanford-Burnham’s stem cell program and research center. Regarded as one of the pioneers of stem cell research, particularly with regard to regenerative medicine applications, Prof. Snyder is an expert on Parkinson’s disease (PD). In fact, he was one of the first scientists to identify neural stem cells and to document the ability of stem cells to migrate to injured or diseased regions of the brain. Prof. Snyder is a recipient of an Early Translational Award from the California Institute for Regenerative Medicine (CIRM) to research into cell based therapies for PD.
Rosario Sánchez-Pernaute, MD, PhD is an internationally recognized expert on the use of stem cells to treat Parkinson’s disease. While Assistant Professor in Neurology at Harvard Medical School Dr. Sánchez-Pernaute was one of the first scientists to demonstrate the possibility of using parthenogenetic stem cells to treat the causes of PD in a non-human primate model.
“We are extremely fortunate to work with two of the world’s leading experts in Parkinson’s disease and stem cell research,” say Dr. Ruslan Semechkin, Vice President of Research and Development, “Prof. Snyder and Dr. Sánchez-Pernaute will add invaluable expertise to our Parkinson’s disease program and provide input into our first non-human primate pre-clinical study which uses the most reliable and predictive model of Parkinson’s in humans.”
For additional information on ISCO, visit the company’s website atwww.internationalstemcell.com
Silver Bull Resources, the Canadian mineral exploration firm primarily focused on their flagship Sierra Mojada (silver, zinc, and lead) project in Mexico, reported some really good news today out of their 1,243 sq. mile Mitzic site, which is on the western edge of the region’s major iron belt (three deposits greater than 650 metric tonnes at 60% Fe currently under development), in the French-speaking West-Central African democracy of Gabon – as the Gabonese Ministry of Mines renewed the site license for another three years.
In addition, the company offered a pertinent status update from the work program conducted on the Mitzic license during the last two years, offering some choice iron mineralization data. As expected, significant iron values appropriate to this iron-rich region (home to BHP Billiton Ltd.’s massive Belinga deposit, projected 30M metric tonnes annual output capacity) were roundly correlated via the empirical data gathered.
Focusing on over 43.5 miles of magnetic highs, the work program at Mitzic validated the presence of banded iron formations containing, on average, 40% iron; however, highly localized supergene/hypogene enrichment (basically a kind of oxidation process generally occurring near the surface) has produced concentration values up to 65% and greater in the field. The magnetite-rich, widespread mineralization is revealed by the geological mapping as occurring in a series of formations with extensive thickening via folding and faulting. Characterized as coarse enough to significantly accelerate beneficiation (crushing/separation of ore), the series of banded iron formations show solid structural repetition occurring in tight chevron folds and thrust faults. The steeply dipping pattern of the banded iron formation units suggests that they also continue at depth.
The company also recently renewed their Ndjole Exploration license (1,243 sq. mile site that is highly prospective for gold/manganese, also in Gabon), upon which some 4k meters of diamond drilling, in addition to extensive soil sampling, has already been performed by SVBL. The company’s acreage footprint in this stable African nation (third highest GDP per capita on the continent) is developing nicely and forms a solid second pillar to the company’s flagship silver project in Mexico, offering shareholders a diverse mineral value proposition.
President and CEO of SVBL, Tim Barry, MAusIMM, who is also the NI 43-101 Qualified Person for the report, commented on the emerging profile for the 100% company-owned Mitzic license, which is well-positioned geographically for future production, being just 37 miles from existing railway and the barge-capable Ogooue River. Barry noted the strong, established regional mineralization model and underscored the fact that Mitzic resides within the same suite of rocks as being one of the major drivers behind SVBL’s positive outlook for the license.
The Export-Import Bank of China has put about $67.2B into sub-Saharan Africa development in the last decade alone, as China moves to secure more raw resource inputs for their economy. With a global appetite for steel not slowing down any time soon, SVBL looks very well-positioned to capitalize for shareholders, while helping to further stabilize the prosperous nation of Gabon (roughly 1.5M population, of which more than half live in the Capital city of Libreville). Gabon is a great place to be setting up shop for the future, as the international developmental presence clearly attests to and SVBL shareholders will no doubt be eager to see further reportage coming out of the company’s operations there.
For more information on Silver Bull Resources, Inc., head on over to the company’s website at: www.SilverBullResources.com
USA Technologies yesterday introduced ePort Mobile™, an innovative product giving retailers and other merchants the capability of accepting credit and debit cards in a mobile environment through USAT’s highly secure, turnkey ePort Connect® service platform. USAT will leverage its extensive experience, over fifteen years, in transitioning traditionally cash-based, unattended retail businesses to cashless payments to make an efficient, effective entry into the multibillion-dollar mobile payments acceptance market.
ePort Mobile will offer:
• Three levels of data security – credit card data is encrypted twice and is transmitted using a proprietary communication protocol;
• Durable, industrial grade card magnetic swipe reader option designed for commercial applications; and,
• The ability to integrate ePort Mobile sales and transaction data with other USAT products, including ePort® G8, EDGE, and SDK – one seamless reporting system for easy access to transaction and operational information across an entire business.
ePort Mobile customers, through USAT’s turnkey ePort Connect service, will also receive:
• Merchant account setup – no need for customers to establish their own merchant accounts;
• The automatic processing, settlement, and transfer of money due to customers into their bank account;
• Online sales and reconciliation reporting that integrates into many existing accounting systems for easy settlement;
• 24/7 customer and consumer support for technical assistance and consumer billing inquiries;
• A simple, blended processing rate that takes the guesswork out of transaction fees; and,
• Access to other services as an integrated solution, including M2M telemetry services and our recently introduced prepaid and loyalty program.
USA Technologies Chairman and CEO, Stephen P. Herbert, commented: “USA Technologies’ leadership position in the industry was predominately built by making it easy for traditionally cash-based businesses to go cashless by offering a seamless, secure and turnkey way to accept cashless payments. ePort Mobile is a natural extension of that value proposition. ePort Mobile customers will be able to benefit from the same high level of service USAT is known for, while having access to all the sales and margin-building benefits a mobile cashless payment system can provide.”
Analysis of Banking Research Associates indicates that the mobile merchant market is made up of over 5.7 billion businesses, representing $233 billion in revenue typically acquired in check or cash-based form.
The ePort Connect service currently has 3,225 customers representing 163,000 connections, many of which submitted the requests for an instant payment solution for supplementary operations that led to this new offering from USAT. Customers have already begun to express how cashless offerings could significantly improve their business results. This exciting new offering allows business owners requiring mobile credit and debit card acceptance to harness similar benefits using a mobile technology solution capable of expanding selling opportunities and reducing costs by decreasing invoicing and improving collections.
“Perhaps more importantly, mobile acceptance through USAT’s ePort Connect service underscores our commitment to the rapidly emerging trends we are all witnessing every day in mobile-based consumer services,” continued Herbert. “Ensuring that our customers are well-positioned for those trends while driving more connections to USAT’s scalable service platform are core elements of our comprehensive mobile strategy. In fact, we believe ePort Mobile can drive connections to our service in a number of ways. Initially, we will focus on our core markets, such as kiosk and vending. In addition, we intend to broaden distribution of ePort Mobile through our various partners. Finally, a key element will include making certain software available to developers that makes it easy and seamless to direct their mobile applications to USAT’s ePort Connect service.”
ePort Mobile is currently entering into field trials with select customers, with pricing and availability to follow. For additional information, access the links below or contact a USAT sales representative at 1-800-633-0340.
For further information, please visit www.usatech.com
Canadian-based Oncolytics Biotech is focused on the novel approach of developing oncolytic viruses as potential therapeutics for patients afflicted with various types of cancer, including lung, pancreatic, and colorectal cancers. The company’s clinical program includes a Phase III trial in head and neck cancer using REOLYSIN, its proprietary formulation of the human reovirus.
The company today announced that it has completed its 36 patient enrollment in its U.K. Phase I clinical trial using intravenously-administered REOLYSIN in combination with cyclophosphamide in patients with advanced malignancies. Eligible patients include those who have been diagnosed with advanced or metastatic solid tumors. These include patients with pancreatic, lung, and ovarian cancers that don’t respond to standard therapy, or for which no standard curative therapy exists.
The study will examine the potential of cylcophosphamide to modulate the immune system’s response to REOLYSIN. The primary objective of the open label, dose-escalating, non-randomized Phase I study is to determine the minimum effective immunomodulastory dosage of cyclophosphamide necessary to obtain successful immune modulation to combat the cancer. Secondary aims of the trial include assessing the safety profile of the combination and gathering any evidence of anti-tumor activity from this drug combination.
The market for much needed cancer therapies is large, offering Oncolytics quite an opportunity. The American Cancer Society estimates there will be more than 1.6 million new cancer cases diagnosed in the U.S. alone in 2012. The U.S. National Institutes of Health estimated than even five years ago, the direct medical cost associated with cancer was in excess of $100 billion.
For additional information about Oncolytics Biotech and REOLYSIN, please visit the company’s website at www.oncolyticsbiotech.com
Today's Top 3
Mina Mar Marketing
The QualityStocks Public Company Sponsor News